The FDA has approved Zegfrovy (sunvozertinib) for locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations.

These findings highlight the dual roles of antioxidants in cancer. Their impact depends on cancer type, stage, and genetic ...

Interstitial lung abnormalities (ILAs) are parenchymal lung changes found on high-resolution CT. In routine use of high-resolution CT, non-specific findings are frequently reported, which has prompted ...

The U.S. FDA has approved a new test for patients with lung cancer to match the correct individuals with a targeted treatment ...

Smoking can cause lung cancer. But not all smokers get lung cancer, and about 25% of all lung cancer patients have never smoked, showing that ... | Genetics And Genomics ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Genetic predisposition: Although rare, certain genetic mutations passed down through families can increase the risk of lung ...

Thermo Fisher secured FDA approval for its Oncomine Dx Express Test, a rapid diagnostic for cancer gene mutations and tumor ...

Data from a Phase I trial of Avmapki Fakzynja also supports the regimen's tolerability and suggests its potential activity in ...

In a bid to better understand how cancer cells power their explosive growth and spread, scientists at Johns Hopkins Medicine ...